Lyophilized Beads for Injectables
14 June 2024
A leading pharmaceutical manufacturer approached Biopharma Group (BG) to develop a bead-format solution for the injectable product.
The objective was to achieve robust lyobeads with a consistent size, which would enable the product to have a longer shelf life. Various excipients were proposed, and, after initial screening, four candidate formulations were designWritten by Biopharma Group's Niloofar Ganji MSc, this case study outlines how the challenge was tackled along with the subsequent results and conclusions.
